Concepedia

Author

Joan Genescà

Universitat Autònoma de BarcelonaORCID

Also Known As

D. Cavan, Genesca, Joan, Genescà,Joan, J Genesca, J Genescà, J Genescá, J. Genesca, J. Genescà, J. Genescá, JOAN GENESCÀ

340

Publications

15.5K

Citations

58

H-Index

113

Concepts

All Affiliations

Universitat Autònoma de BarcelonaVall d'Hebron Institut de RecercaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasInstituto de Salud Carlos IIIUniversitat de Barcelona
JG

About

Joan Genescà is an author at Universitat Autònoma de Barcelona specializing in medicine, hepatology, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

43

6.2K

2

Health Sciences

10

10

949

3

Public Health

3

3

229

4

Natural Sciences

1

1

20

5

Allergy

1

1

11

Joan Genescà

×

108

Publications

11.1K

Citations

50

H-Index

YearCitations

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

Marı́a Martell, Juan Ignacio Esteban, Josep Quer,

Journal of Virology

1992

930

HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN

L. Viladomiu, Antonio González, M Roget,

The Lancet

1989

900

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Càndid Villanueva, Agustı́n Albillos, Joan Genescà,

The Lancet

2019

638

A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding

Enric Reverter, Puneeta Tandon, Salvador Augustín,

Gastroenterology

2013

386

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

Juan G. Abraldeṣ, Christophe Bureau, Horia Ştefănescu,

Hepatology

2016

363

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

Richard Moreau, Joan Clària, Ferrán Aguilar,

Journal of Hepatology

2019

332

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

Juan G. Abraldeṣ, Càndid Villanueva, Carles Aracil,

Gastroenterology

2016

322

Cardiac alterations in cirrhosis: reversibility after liver transplantation

Mireia Torregrosa, Santi Aguadé, Laura Dos,

Journal of Hepatology

2004

317

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

Annalisa Berzigotti, Agustı́n Albillos, Càndid Villanueva,

Hepatology

2016

315

High Prevalence of Hepatitis C Virus Infection in Diabetic Patients

Rafael Simó, Cristina Hernández, Joan Genescà,

Diabetes Care

1996

279

Page 1